Ovoca Bio announces that the Company will be attending the 25th annual BIO-Europe Partnering Conference, taking place from 11-13 November 2019, in Hamburg, Germany.
Ovoca Bio plc is pleased to announce that on 2nd September 2019 its subsidiary, IVIX, received patent No 6552960 in Japan covering pharmaceutical use for a list of peptide variants based on BP-101.
The 37th BIO International Convention in Philadelphia, United States.
|March 24, 2020||Acquisition of Remaining Minority Shareholding in IVIX LLC|
|September 16, 2019||Interim Results|
|September 12, 2019||Filing of Marketing Authorisation Application with Russian Ministry of Health for BP-101|
|June 28, 2019||Annual Report 2018|
|May 25, 2018||Annual Report 2017|
|June 30, 2017||Annual Report 2016|
|November 20, 2019||Ovoca Bio plc BP-101 Presentation|
|March 29, 2019||Ovoca Bio plc | Libicore Presentation|
|July 27, 2018||Ovoca Bio plc | Libicore Presentation|